Published in Pain on July 30, 2007
Early Detection of Taxane-Induced Neuropathy in Women With Breast Cancer | NCT02549534
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol (2007) 1.47
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol (2011) 1.24
Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience (2011) 1.16
Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain (2012) 1.11
The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience (2010) 1.10
Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat. Neuroscience (2011) 1.10
Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy. J Pain (2013) 1.06
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine (2012) 1.03
Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel. Eur J Neurosci (2011) 1.00
Mechanical sensitization of cutaneous sensory fibers in the spared nerve injury mouse model. Mol Pain (2013) 0.95
Mitotoxicity in distal symmetrical sensory peripheral neuropathies. Nat Rev Neurol (2014) 0.92
Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons. Mol Pain (2010) 0.91
Pain in cancer survivors. J Clin Oncol (2014) 0.89
Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy. Anesthesiology (2014) 0.89
Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum (2012) 0.88
Increased spinal cord Na⁺-K⁺-2Cl⁻ cotransporter-1 (NKCC1) activity contributes to impairment of synaptic inhibition in paclitaxel-induced neuropathic pain. J Biol Chem (2014) 0.83
Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ. Pain (2015) 0.83
Effect of ethyl pyruvate on Paclitaxel-induced neuropathic pain in rats. Korean J Pain (2013) 0.82
Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain ketamine, astrocytic inhibitor and pain. Mol Pain (2010) 0.82
Targeting neuroprotection as an alternative approach to preventing and treating neuropathic pain. Neurotherapeutics (2009) 0.82
Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic pain. Pain (2013) 0.82
Genesis of anxiety, depression, and ongoing abdominal discomfort in ulcerative colitis-like colon inflammation. Am J Physiol Regul Integr Comp Physiol (2014) 0.81
Intact cutaneous C fibre afferent properties in mechanical and cold neuropathic allodynia. Eur J Pain (2009) 0.81
Pain in cancer survivors. Br J Pain (2014) 0.81
Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems. Pain Ther (2015) 0.81
Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer. Cancer Nurs (2011) 0.78
Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Res (2016) 0.78
An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US. J Pain Res (2017) 0.78
Paclitaxel-induced epithelial damage and ectopic MMP-13 expression promotes neurotoxicity in zebrafish. Proc Natl Acad Sci U S A (2016) 0.76
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy. J Neurophysiol (2014) 0.76
Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo. PLoS One (2016) 0.76
Chemotherapy induced peripheral neuropathic pain. Korean J Anesthesiol (2014) 0.76
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain. Mol Pain (2017) 0.75
EXPRESS: Methylcobalamin ameliorates neuropathic pain induced by vincristine in rats: Effect on loss of peripheral nerve fibers and imbalance of cytokines in the spinal dorsal horn. Mol Pain (2016) 0.75
HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy. Pain (2017) 0.75
NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT. Physiol J (2013) 0.75
Effects of paclitaxel on mechanical sensitivity and morphine reward in male and female C57Bl6 mice. Exp Clin Psychopharmacol (2016) 0.75
Chemotherapy-induced peripheral neuropathy. Part II. Prevention. Contemp Oncol (Pozn) (2012) 0.75
A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy. Exp Ther Med (2016) 0.75
Suppressive effects of D-glucosamine on the 5-HT sensitive nociceptive units in the rat tooth pulpal nerve. Biomed Res Int (2014) 0.75
Neuropathic pain-induced enhancement of spontaneous and pain-evoked neuronal activity in the periaqueductal gray that is attenuated by gabapentin. Pain (2017) 0.75
Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound. Pharmaceuticals (Basel) (2010) 0.75
Early life vincristine exposure evokes mechanical pain hypersensitivity in the developing rat. Pain (2017) 0.75
[Pain as adverse drug reaction]. Wien Med Wochenschr (2012) 0.75
Ethical guidelines for investigations of experimental pain in conscious animals. Pain (1983) 17.70
Painful neuropathy: altered central processing maintained dynamically by peripheral input. Pain (1992) 2.78
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain (2006) 2.51
Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients. Pain (2004) 2.38
Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs (2003) 2.35
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain (2004) 2.34
Spontaneous pain, both neuropathic and inflammatory, is related to frequency of spontaneous firing in intact C-fiber nociceptors. J Neurosci (2006) 2.32
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain (2001) 2.28
Mitochondrial trafficking to synapses in cultured primary cortical neurons. J Neurosci (2006) 2.26
Abeta-fiber nociceptive primary afferent neurons: a review of incidence and properties in relation to other afferent A-fiber neurons in mammals. Brain Res Brain Res Rev (2004) 1.90
Transient receptor potential vanilloid 4 is essential in chemotherapy-induced neuropathic pain in the rat. J Neurosci (2004) 1.87
Progressive tactile hypersensitivity: an inflammation-induced incremental increase in the excitability of the spinal cord. Pain (1996) 1.85
Cutaneous sensory receptors in the rat foot. J Neurophysiol (1993) 1.64
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol (2006) 1.59
Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol (2006) 1.58
Spontaneous discharge originates in the dorsal root ganglion at the onset of a painful peripheral neuropathy in the rat. Neurosci Lett (1992) 1.54
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40
Uninjured C-fiber nociceptors develop spontaneous activity and alpha-adrenergic sensitivity following L6 spinal nerve ligation in monkey. J Neurophysiol (1999) 1.36
Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons. J Neurophysiol (1992) 1.36
Ongoing activity in severed nerves: source and variation with time. Brain Res (1978) 1.36
Degeneration of myelinated efferent fibers induces spontaneous activity in uninjured C-fiber afferents. J Neurosci (2002) 1.36
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett (2006) 1.33
Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit. Neuroscience (2006) 1.30
Role of protein kinase Cepsilon and protein kinase A in a model of paclitaxel-induced painful peripheral neuropathy in the rat. Neuroscience (2001) 1.28
Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett (2005) 1.26
Changes in sensory processing in the spinal dorsal horn accompany vincristine-induced hyperalgesia and allodynia. Pain (2003) 1.24
Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol (2000) 1.23
Ongoing activity in peripheral nerve: injury discharge. Exp Neurol (1974) 1.21
Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neuroscience (2005) 1.21
Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain (2004) 1.12
Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol (1998) 1.11
Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. Ann N Y Acad Sci (2005) 1.07
Multiple interacting sites of ectopic spike electrogenesis in primary sensory neurons. J Neurosci (2005) 1.06
Development of spontaneous activity and mechanosensitivity in axotomized afferent nerve fibers during the first hours after nerve transection in rats. J Neurophysiol (1995) 1.05
Nociceptor hyper-responsiveness during vincristine-induced painful peripheral neuropathy in the rat. J Neurosci (1998) 1.01
Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Ann N Y Acad Sci (2005) 0.98
Spontaneous activity of primary afferent neurons in diabetic BB/Wistar rats. A possible mechanism of chronic diabetic neuropathic pain. Diabetes (1985) 0.96
Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. Anticancer Res (2005) 0.95
Altered temporal pattern of evoked afferent activity in a rat model of vincristine-induced painful peripheral neuropathy. Neuroscience (2003) 0.89
Chemotherapy-induced allodinia: neuroprotective effect of acetyl-L-carnitine. In Vivo (2005) 0.89
Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats. Cancer Chemother Pharmacol (2004) 0.87
Mitochondria in fine afferent nerve fibres of the knee joint in the cat: a quantitative electron-microscopical examination. Cell Tissue Res (1994) 0.86
Three-dimensional reconstruction of scleral cold thermoreceptors of the cat eye. J Comp Neurol (2001) 0.83
Neurologic Complications of Cancer Therapy. Curr Treat Options Neurol (1999) 0.82
Prolonged injury discharge in unmyelinated nerve fibres following transection of the sural nerve in rats. Neurosci Lett (1996) 0.81
Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol (2003) 3.80
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial. CMAJ (2010) 3.46
Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction. Pain (2006) 2.51
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer (2003) 2.48
Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy. Pain (2004) 2.34
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster. Pain (2009) 2.01
A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation (2004) 1.87
The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain (2006) 1.59
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol (2006) 1.59
Abnormal contralateral pain responses from an intradermal injection of phenylephrine in a subset of patients with complex regional pain syndrome (CRPS). Pain (2004) 1.55
Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain (2015) 1.55
Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells. Exp Neurol (2007) 1.47
Dietary fat and protein interact in suppressing neuropathic pain-related disorders following a partial sciatic ligation injury in rats. Pain (2004) 1.43
Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth Analg (2006) 1.40
Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci Lett (2006) 1.33
Sympathetic sprouting and changes in nociceptive sensory innervation in the glabrous skin of the rat hind paw following partial peripheral nerve injury. J Comp Neurol (2006) 1.25
Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol (2011) 1.24
Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice. Mol Pain (2010) 1.18
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. BMC Neurol (2011) 1.11
Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain (2012) 1.11
Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain. Pain (2008) 1.07
Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia. Sci Transl Med (2011) 1.05
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain. Mayo Clin Proc (2006) 1.03
A hypothesis for the cause of complex regional pain syndrome-type I (reflex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med (2010) 1.02
Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies. Pain Med (2008) 1.01
Persistent low-frequency spontaneous discharge in A-fiber and C-fiber primary afferent neurons during an inflammatory pain condition. Anesthesiology (2007) 0.98
Cutaneous tactile allodynia associated with microvascular dysfunction in muscle. Mol Pain (2008) 0.93
Imaging studies in Freund's complete adjuvant model of regional polyarthritis, a model suitable for the study of pain mechanisms, in the rat. Arthritis Rheum (2011) 0.88
CNS mastitis: nothing to worry about? Vet Microbiol (2008) 0.85
Characterization of a model of cutaneous inflammatory pain produced by an ultraviolet irradiation-evoked sterile injury in the rat. J Neurosci Methods (2005) 0.84
Neuropathic pain: a crisis of definition? Anesth Analg (2003) 0.83
A multicenter, double-blind, randomized, placebo-controlled crossover evaluation of a short course of 4030W92 in patients with chronic neuropathic pain. J Pain (2002) 0.83
Systemic glucocorticoid therapy reduces pain and the number of endoneurial tumor necrosis factor-alpha (TNFalpha)-positive mast cells in rats with a painful peripheral neuropathy. J Pharmacol Sci (2008) 0.82
Unpleasant odors increase pain processing in a patient with neuropathic pain: psychophysical and fMRI investigation. Pain (2005) 0.80
Novel therapies for the control and prevention of neuropathic pain. Neurotherapeutics (2009) 0.78
Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain. J Pain (2013) 0.77
Peripheral neuropathy in a woman with breast cancer. J Pain (2006) 0.77
Objectifying CRPS-I. Pain (2008) 0.76
Response to "A new definition of neuropathic pain". Pain (2012) 0.75
Questions concerning the incidence and prevalence of complex regional pain syndrome type I (RSD). Pain (2003) 0.75
Dissociation between cutaneous and deep sensibility in central post-stroke pain (CPSP). Pain (2002) 0.75